Antibodies of TIA1


1 antibodies are included.     

 Released    NotSatisfied    Submitted    NotReviewed    OnHold    Submitting    Experimented   
RBP Antibody InfoPrimary-HepG2Secondary-HepG2Primary-K562Secondary-K562Primary-UBERONPrimary-Hela
TIA1Product_ID: RN014P
Lot_ID: 1
Source: MBLI
Target Name: TIA1-human		 HepG2_MBLI_RN014P_001_TIA1.png<br>Caption: IP-Western Blot analysis of HepG2 whole cell lysate using TIA1 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-TIA1 antibody (lanes under 'TIA1').
 TIA1_Secondary_Western.jpg<br>Caption: Western blot following shRNA against Tia1 in K562 and HepG2 whole cell lysate using Tia1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 2 and 3 are two different shRNAs against Tia1. Lanes 5-7 follow the same pattern, but in HepG2. Tia1 protein appears as the green band, GAPDH serves as a control and appears in red.
 MBLI_RN014P_001_TIA1.png<br>Caption: IP-Western blot analysis of K562 whole cell lysate using TIA1 specific antibody. Lane 1 is 2.5% of 0.5mg input lysate, lane 2 is 2.5% of supernatant after immunoprecipitation and Lane 3 is 50% of IP enrichment using rabbit polyclonal Anti-TIA1pAb. The last three lanes are the same pattern, but with IgG control instead of TIA1 antibody.
 TIA1_Secondary_Western.jpg<br>Caption: Western blot following shRNA against Tia1 in K562 and HepG2 whole cell lysate using Tia1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 2 and 3 are two different shRNAs against Tia1. Lanes 5-7 follow the same pattern, but in HepG2. Tia1 protein appears as the green band, GAPDH serves as a control and appears in red.